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INTRODUCTION
For patients with neurogenic bladder dysfunction-either due to spinal cord injury (SCI) or to lesions or diseases of the central nervous system, such as multiple sclerosis (MS) or spina bifidaintermittent catheterization (IC) is the recommended standard treatment. 1 Indeed, even if no randomized or quasi-randomized controlled trials have been designed to compare catheter methods, a few prospective cohort studies have found that the occurrence of urinary tract infections is lower in people using intermittent catheters. 2 To empty their bladder, those patients (or their caregivers) have to insert a catheter via the urethra into the bladder several times a day. According to the European Association of Urology guidelines, the aseptic method of IC-during which the patient does not directly touch the cathetershould be preferred. 1 Indeed, in an outpatient setting this method is more feasible than the sterile method, 1 while it significantly reduces the risk of catheter contamination compared with clean IC. 3 However, to our knowledge, the catheterization habits of French patients using hydrophilic-coated catheters with the 'no-touch' method for selfcatheterization have never been described.
Several types of catheters are available for IC, including uncoated catheters, gel-coated catheters and hydrophilic-coated catheters. 4 The VaPro catheter (Hollister Incorporated, Libertyville, IL, USA) belongs to the latter category, relies on the 'no-touch' method, and is designed to be easy-to-use. Its protective sleeve prevents direct hand contact with the catheter during preparation and catheterization. The catheter is ready to use right out of the packaging, requiring no extra steps or additional water.
The VaPro hydrophilic catheter has several features designed to reduce contamination risks: (i) the already mentioned protective sleeve; (ii) a protective tip that helps the catheter to bypass bacteria in the distal urethra, hence reducing the risk of carrying bacteria further into the urinary tract; and (iii) a ring cap that helps keep the protective tip clean and protected from external contamination once the packaging is open.
This manuscript describes the demographic data of a sample of French neurogenic bladder patients who perform IC using hydrophilic-coated catheters, together with patients' general opinion regarding the new VaPro catheter.
MATERIALS AND METHODS

Study design and objectives
A prospective, interventional, multi-center, open-label and randomized crossover study was performed between November 2009 and May 2010. Patients were recruited from 11 French centers, spread over the whole territory and mixing teaching and non-teaching settings. The study aimed at describing the current catheterization habits of the French neurogenic bladder patients using IC, including number of catheterizations per day and associated medical treatment for neurogenic detrusor overactivity, as well as evaluating the ease of use (primary objective), reliability and patients' comfort and patients' acceptance (secondary objectives) of the new 'no-touch' VaPro catheter. The questionnaire used for collecting data was developed by investigators.
The study design is described in Figure 1 . Data were collected at three visits over a period of 30 days. At inclusion, patients' baseline characteristics and current catheterization practices were evaluated and training in using the VaPro catheter was provided. Afterwards, patients were randomized into two groups: (1) 15 days using conventional catheters, followed by 15 days of VaPro catheters and (2) 15 days using VaPro catheters, followed by 15 days of conventional catheters. Randomization was stratified per center. Patients were questioned about their experiences with the catheter used during the preceding period at day 15 (visit 1) and day 30 (visit 2). At day 30, patients were asked to express their overall opinion towards the VaPro catheter. Patients were then requested to rate both catheters on several aspects, using a four-point ordinal rating scale for most items.
Tolerability was assessed at each visit; urine analysis was performed using urine test strips.
Patients
Eligible patients were men and women (age 18-65 years) with neurogenic bladder using IC to empty their bladder at least four times a day. Patients were included if they used 'no-touch' catheters, were trained to use the 'no-touch' technique recommended by the manufacturer, and had a stable medical condition for the last 3 months. Major cognitive problems, symptomatic urinary infection, non-urethral catheterization, a previous procedure to replace or enlarge the bladder and/or treatment with chemo-or radiotherapy were the main exclusion criteria.
Statistical analysis
The calculated sample size of 100 patients was based on the hypothesis that the VaPro catheter was considered 'easy' or 'fairly easy' by 60% of patients, compared with 40% of patients using conventional catheters, with a power of 80%, an a-risk of 5% and an intra-subject correlation of 0.3.
The primary objective was analyzed using a non-parametric exact w 2 -test of paired proportions adjusted for the stratification factors considered in the randomization, in conformity with the recommendations of the EMA. A period effect was tested.
The ease of use of the various self-catheterization phases, the number of daily catheterizations and the number of catheters used were compared between catheter types using paired tests: the Wilcoxon test for quantitative data and the McNemar w 2 -test for ordinal variables. Comparisons with baseline were performed by the non-parametric Kruskal-Wallis or w 2 -test. Frequency of maneuvers involving catheter contamination and patients' comfort were analyzed using regression methods. All tests were evaluated with a 5% bilateral error risk, using SAS and R programs. 
RESULTS
Patient characteristics
In total, 106 patients were randomized: 49 out of 52 patients in group 1 vs 48 out of 54 patients in group 2 completed the study (Figure 1 ). The dropout rate was low and comparable between groups. Reasons for discontinuation were withdrawal of informed consent (N ¼ 2), protocol violations (N ¼ 2), early abandon after 2 days (N ¼ 1), lost to follow-up (N ¼ 1), renal transplantation (N ¼ 1), serious adverse event (N ¼ 1: thrombophlebilitis) and desire to continue using the VaPro catheter because of high satisfaction after the first treatment period (N ¼ 1).
Patients' baseline characteristics are described in Tables 1 and 2 . The median age was 46 years (19-64 years) and the median disease duration was 11 years (0.33-52 years). Patients had been using IC for a median time of 4 years (0.17-23 years), with 2/3 of them practising IC for Z2 years. Approximately 60% of patients suffered from SCI, of which 55% had a complete lesion (American Spinal Injury Association (ASIA) score A). The underlying pathology was significantly different between both genders (Po0.001): SCI prevailed among males (71.4%), while MS was predominant among females (52.9%). The underlying pathology also differed significantly among the 11 centers (Po0.001). Indeed, four centers included mainly SCI patients, representing 69.6% (39/56) of SCI patients of the study, while one center was specialized in MS management and included 44.0% (11/25) of all MS patients. Patients from all centers were equally distributed among both treatment groups. It has to be noted that patients with SCI were significantly younger than patients with other pathologies (median age 41.5 vs 48.0 years).
Current catheterization practices
The majority of patients used self-catheterization 5 or 6 times a day (Tables 1 and 2 ). Women performed catheterization more frequently than men (Po0.01, Kruskal-Wallis), but there were no differences in catheterization frequency according to pathologies. Median time of IC use was longer for SCI patients than for patients with other pathologies (5.5 vs 3.0 years), but differences were not significant. About three out of four patients needed accessories to perform their self-catheterization with greater ease or hygiene, for example, moist Aseptic VaPro catheter in French neurogenic bladder population P Denys et al tissues to clean the area and/or to hold the catheter, external water source to hydrate the catheter and so on. (Tables 1 and 2 ). Each step of the current IC process was rated as 'easy' or 'rather easy' by a large majority of patients (Table 3) . The reported ease of use was not significantly influenced by gender, underlying pathology or experience with IC, except for the catheter preparation step, which was rated as easier by patients performing IC for 42 years compared with patients with o2 years experience (P ¼ 0.024). In general, patients felt comfortable while catheterizing, although 40% of them experienced some discomfort during catheter insertion (Table 4) . Interestingly, we observed a lower discomfort at insertion and withdrawal after voiding in SCI patients with complete lesions (ASIA score A). Again, comfort during bladder emptying or catheter withdrawal tended to increase with IC experience (Table 5) . Wetting or soiling oneself or the catheter, finger contamination and accidental insertion into the vagina were encountered rather frequently, especially by patients with o2 years experience ( Table 6 ). The problem of catheter soiling, necessitating the use of a second catheter, was significantly more common among women (59.4%) than among men (33.3%) (P ¼ 0.031, w 2 ).
Overall opinion on VaPro catheter
Removal of the ring cap and progression of the VaPro catheter through the protection were rated as 'easy' or 'rather easy' by about 90% of patients, and 450% of patients had no difficulties inserting the protective tip into the meatus (Tables 7 and 8 ). The major advantage of the VaPro catheter seems to be its reliability: 43/4 of patients felt confident and more secure with the new catheter. In addition, the new catheter enabled one out of three patients to carry fewer accessories for catheterization. Importantly, men were significantly more positive about the VaPro catheter than women (Table 7) : they did not only feel more confident and secure, but they also found the catheter easier to use. Therefore, it is not surprising that significantly more men (43%) than women (21%) wanted to continue using the VaPro catheter (w 2 -test; P ¼ 0.030 if undecided patients were left out) and would recommend the catheter to other people requiring IC (Figure 2) . Similarly, patients suffering from SCI were more positive about the VaPro catheter than patients suffering from other pathologies (Table 8 and Figure 2) .
In general, discomfort (Table 5 ) or problems during IC (Table 6 ) were not reported more frequently with the VaPro catheter than before the study, especially compared with the population of patients who had o2 years experience with their conventional catheter. Finger contamination occurred less frequently with the VaPro catheter than with conventional catheters used before the study.
Tolerability
Adverse events were reported by 19 patients; 13 of them were possibly or probably related to catheter use (Table 9 ). 
DISCUSSION
To our knowledge, this is the first study that extensively describes this patient population and their current IC habits in a relatively large sample from 11 centers. SCI appears to be the most common underlying pathology among males, while 450% of females who need IC suffer from MS. Although in this study population, SCI patients were generally younger and had shorter disease duration than patients suffering from other pathologies, they tended to be more experienced in IC use. This is not surprising, as SCI often has a sudden traumatic onset and therefore immediately causes bladder dysfunction, whereas other pathologies such as MS often have a more gradual course and bladder dysfunction starts occurring only several years after onset. Indeed, there was a tendency towards the use of fewer accessories in men (difference only statistically significant for mirror use) (Table 1) . Moreover, this study demonstrated that catheterization frequency was higher among women (usually 5-6 times per day) than among men (usually 4-5 times per day) ( Table 1 ). There were no obvious differences in catheterization frequency according to underlying pathologies (Table 2) . In general, every important step of the IC process was experienced as being (rather) easy by at least 90% of patients (Table 3) . Moreover, discomfort during IC was relatively mild, with catheter insertion being the least comfortable step (Table 4) , although less discomfort was observed in patients with complete SCI lesions. These data indicate that the majority of patients in our study have very strong catheterization habits, as 2/3 of them have been practising IC for X2 years with high ease of use and comfort. In addition, these results allow us to highlight that accepting and managing IC requires a lot of experience.
Furthermore, this study demonstrated the feasibility of IC with the VaPro catheter. Its major advantage is its perception of reliability, with about 4/5 of patients indicating that they felt confident and secure with the new catheter (Tables 7, 8 ). It is most likely that the new features of the VaPro catheter designed to reduce the contamination risk (that is, protective sleeve, protective tip and ring cap) have an important role in this perception. Indeed, the reported number of contaminations was significantly reduced with the new catheter (Table 6 ). However, the tip might have also been a factor impacting its ease of use, as only half of the patients rated insertion into the meatus as 'rather easy' (Tables 7, 8 ). Nevertheless, discomfort (Table 5) or problems during IC (Table 6) were not reported more frequently with the VaPro catheter than before the study. Tolerability was comparable for both types of catheters. After 15 days of use, 41/3 of the study population wanted to continue using the VaPro catheter and 450% of patients would recommend it to other people who need IC (Figure 2 ). This acceptance rate is rather high (and comparable to acceptance rates for other hydrophilic-coated 'no-touch' catheters), 5 especially given the fact that the current population was shown to have very strong catheterization habits established over a long period of time. Indeed, from our study, it is clear that the ease of use and comfort during catheterization increase with the experience in catheter use. When patients performing IC for 42 years were compared with patients with o2 years experience, catheter preparation was easier, bladder emptying and catheter withdrawal after voiding tended to be more comfortable (Table 5) , and contamination and accidental catheter insertion into the vagina tended to occur less frequently (Table 6) . It has to be taken into account that experienced patients, who constituted the majority of the study population, might be reluctant to switch catheters. Given the latter consideration and the fact that patients in the current study were only allowed to get accustomed to handling the VaPro catheter during 15 days, acceptance of and satisfaction with the new catheter were high.
Interestingly, patients' opinion on the VaPro catheter significantly differed between genders, with 69% of men vs 27% of women stating that they would recommend this catheter to others (Figure 2) . Although gender differences of opinion regarding intermittent catheters have been previously described, 5, 6 a clear explanation has never been given. Differences in anatomy and/or bladder volume might have a role. Indeed, women have more problems accessing the meatus, because of a less obvious anatomy and a poor visual access. 6 As a result, in our study population, accidental catheter insertion into the vagina has already occurred in 80% of women with o2 years of experience in IC (Table 6) . Alternatively, the differences in overall opinion on the VaPro catheter between men and women might be explained by differences in underlying pathologies (Table 1) . It has to be noted that women may have more tolerability issues than men. Statistically significant differences in overall opinion were also observed between patients with and without SCI (Table 8) .
Hence, it is clear that each patient should individually weigh the reliability of the VaPro catheter against its ease of use. The VaPro catheter is an acceptable and well-tolerated alternative to the existing hydrophilic-coated catheters relying on a 'no-touch' method for patients who are prepared to get used to handling a new type of catheter.
There are limitations to this study. There were twice as many men as women in this patient sample. Moreover, SCI and MS patients were highly represented in certain centers. However, thanks to the stratification method per center, centers are unlikely to have affected the study results.
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